• No results found

Familial hypercholesterolemia. The determination of phenotype - Contents

N/A
N/A
Protected

Academic year: 2021

Share "Familial hypercholesterolemia. The determination of phenotype - Contents"

Copied!
2
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

UvA-DARE is a service provided by the library of the University of Amsterdam (https://dare.uva.nl)

UvA-DARE (Digital Academic Repository)

Familial hypercholesterolemia. The determination of phenotype

Jansen, A.C.M.

Publication date

2003

Link to publication

Citation for published version (APA):

Jansen, A. C. M. (2003). Familial hypercholesterolemia. The determination of phenotype.

General rights

It is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s)

and/or copyright holder(s), other than for strictly personal, individual use, unless the work is under an open

content license (like Creative Commons).

Disclaimer/Complaints regulations

If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please

let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material

inaccessible and/or remove it from the website. Please Ask the Library: https://uba.uva.nl/en/contact, or a letter

to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You

will be contacted as soon as possible.

(2)

Contents s

Chapterr 1. General introduction and outline of this thesis 7

Chapterr 2. Phenotypic variability in familial hypercholesterolemia: an update 17

Chapterr 3. The contribution of classical risk factors to cardiovascular disease 31 inn familial hypercholesterolemia. Data in 2400 patients

Chapterr 4. Diagnosing familial hypercholesterolemia. The need for genetic 45 testing.. A study in 2400 FH heterozygotes

Chapterr 5. Data collection from medical records: Guidelines for the 59 physician-scientist t

Chapterr 6. Cardiovascular disease risk and genetic variation. A study in 2000 71 familiall hypercholesterolemia heterozygotes

Chapterr 7. Susceptibility genes for all-cause mortality from familial 85 hypercholesterolemia:: a large parent-offspring study

Chapterr 8. Genetic determinants of plasma HDL-cholesterol in familial 97 hypercholesterolemia.. A study in 1000 FH heterozygotes

Chapterr 9. The risk of hyperhomocysteinemia in patients with familial 113 hypercholesterolemia a

Chapterr 10. PON-1 levels, PON-1 genotype and prevalence of symptomatic 125 cardiovascularr disease in subjects with familial

hypercholesterolemia. .

Chapterr 11. Summary

137 7

Samenvattingg 145 Listt of participating Lipid Clinics 155

Dankwoordd 159 Curriculumm Vitae 177

Referenties

GERELATEERDE DOCUMENTEN

Topographic maps for LI (left) and HI (right), at Pz, for No-Go trials in the Go/No-Go task. Visual representation of one trial in the SSRT. a blue circle) on Go trials (75%

Stopping the “World’s Greatest Threat”: Canadian Policy and Rhetoric towards the Iranian Nuclear Program during Stephen Harper’s Conservative Government, 2006-2015.. by

I think joy, and like, you know, just taking care of yourself and the people around you is really important to this work because we’re in it for the long haul. we have to take care

German’s report, the Corporate Registration program plays a key role in GPEB’s regulatory framework, and is a principal mechanism through which GPEB maintains control over

Britton (1997) concluded that race and gender are contributing factors in stress and further identified the need for future researchers to explore how these intersections

These structural investigations into the mechanism for germ-line antibody recognition of carbohydrate antigens utilizing chlamydial-specific and anti-lipid A antibodies

Our structural analysis revealed that while the N- terminal region of TbFam50.360 adopted a three-helical structure similar to previously characterized trypanosome surface

I showed that data on the structural differences between the native and aggregated forms of the prion protein, obtained from multiple structural proteomics approaches